4th Quarter 2018
Key topics in this quarter’s edition include:
- ravulizumab: Treatment of patients with paroxysmal nocturnal hemoglobinuria
- siponimod: Treatment of secondary progressive multiple sclerosis
- sotagliflozin: In combination with insulin therapy, to improve glycemic control in adults with type 1 diabetes mellitus
Top